AUTHOR AND EDITOR INFORMATION

Section 1 of 11  

• Authors and Editors
• Introduction
• Clinical
• Differentials
• Workup
• Treatment
• Medication
• Follow-up
• Miscellaneous
• Multimedia
• References

INTRODUCTION

Section 2 of 11  

• Authors and Editors
• Introduction
• Clinical
• Differentials
• Workup
• Treatment
• Medication
• Follow-up
• Miscellaneous
• Multimedia
• References

Background

The Candida fungus is both normal flora and an invasive pathogen. The range of infection with Candida species varies from a benign local mucosal membrane infection to disseminated disease. Severe disease is typically associated with an immunocompromised state including those vulnerable to iatrogenic pathogens in the intensive care unit or those with predisposing immunologic conditions such as malignancy, organ dysfunction, or immunosuppressive therapy.

Pathophysiology

Candida is a unicellular yeast whose cells reproduce by budding. This organism can flourish in most environments. It frequently colonizes the oropharynx, skin, mucous membranes, lower respiratory, and gastrointestinal and genitourinary tracts. Pathogenesis occurs with increased fungal burden and colonization, such as in the setting of broad-spectrum antimicrobial agents; breakdown of normal mucosal and skin barriers, which can occur with indwelling intravascular devices, recent surgery/trauma or tissue damage secondary to chemotherapy or radiation; or immune dysfunction secondary to disease states or iatrogenic conditions.
 
Disease manifestation of candidal infection can vary with type of host immunodeficiency. Lymphocytes and cell-mediated immunity are important in the prevention of mucosal candidiasis. Therefore, patients with T-cell deficiency, such as human immunodeficiency virus (HIV), have a propensity to develop recurrent and/or persistent mucocutaneous candidiasis. Patients with neutropenia are at risk for invasive candidiasis and candidemia as functioning monocytes and polymorphonuclear cells are responsible for killing pseudohyphae and blastospores. Complement and immunoglobulins are necessary for intracellular killing of the organisms and patients with deficiencies can have a more prolonged and complicated course of candidal infection.

Frequency

United States

• Three quarters of women experience vaginitis in their lifetime, and 30% of vaginitis is caused by Candida. Vaginitis accounts for 10 million office visits per year.
• Candida is the fourth most common cause of nosocomial bloodstream infection in the United States.
• Invasive candidiasis is the most common invasive fungal infection in the United States. There is an increasing shift toward infections caused by non-albicans Candida species with 40-60% of the species currently being reported as non-albicans species.

International

• Internationally, Candida epidemiology is similar to that of the United States.
• Non-albicans Candida accounted for 70% of candidemia in a Northern Indian pediatric intensive care unit. Candida species isolated were Candida tropicalis (48.4%), C albicans (29.7%), C guilliermondii (14.1%), C krusei (6.3%), and C glabrata (1.6%).
• Fungal keratitis is more prevalent in the tropics; therefore, Candida accounts for proportionately more fungal corneal isolates at temperate latitudes.

Mortality/Morbidity

• Invasive candidiasis has a mortality rate of 40-50%, with an estimated cost of $40,000 per episode.
• Neonates and children have better outcomes with approximately 20% mortality rate for candidemia.
• Risk factors for death or poor prognosis are age, failure to remove central lines, malnutrition, and non-albicans fungemia.

Race

• No racial predilection exists for infection with Candida.

Sex

• Three quarters of all women experience at least one episode of vulvovaginal candidiasis in their lifetime, and about one half of these women experience a recurrence.

Age

• Elderly persons with high Acute Physiology and Chronic Health Evaluation (APACHE) II scores as well as neonates with low gestational age, low APGAR scores, and congenital malformations are at high risk for candidal infection.

CLINICAL

Section 3 of 11  

• Authors and Editors
• Introduction
• Clinical
• Differentials
• Workup
• Treatment
• Medication
• Follow-up
• Miscellaneous
• Multimedia
• References

History

Candidal infection has a wide range of clinical manifestations from self-limited local mucocutaneous disease to severe sepsis with multiorgan system failure.
 
Local mucous membrane infections

Oral candidiasis, also referred to as thrush, is characterized by creamy white, curd-like patches on the tongue and oral mucosa. These patches are a pseudomembrane of Candida, desquamated epithelial cells, leukocytes, bacteria, keratin, necrotic tissue, and food debris. Chronic atrophic candidiasis, or denture sore mouth, is a chronic inflammatory reaction with epithelial thinning under dental plates. Candidal leukoplakia is firm, white plaques affecting the cheeks, lips, and tongue, which frequently have a protracted course and can be precancerous. Angular cheilitis is characterized as erythema and fissuring at the corners of the mouth. Risk factors for oral infection include antibiotic use, immunodeficiency, xerostomia, inhaled corticosteroids, and denture use. Symptoms include dry mouth, loss of taste, and occasionally, pain with eating.
 
Candida esophagitis is most commonly associated with treatment of hematopoietic or lymphatic malignancies. It is also an AIDS-defining illness, though patients with Candida esophagitis and no underlying illness have been reported. Symptoms include dysphagia, sensation of obstruction on swallowing, retrosternal chest pain, nausea, and vomiting. Definitive diagnosis is made by endoscopic biopsy. On endoscopy, white plaques similar to thrush may be present; ulcerations, pseudomembrane formation, and diverticula may also be seen. Candidal esophagitis can occur concomitantly with herpes simplex and cytomegalovirus infection in severely immunocompromised patients.
 
Other locations of the gastrointestinal tract are often infected with Candida. Lesions may be found in the stomach and small and large intestines most commonly in patients with neoplastic disease.
 
Candidal vaginitis is the most common form of mucosal candidiasis. Vulvovaginal candidiasis is usually secondary to overgrowth of normal flora Candida species in the vagina. Bacteria such as Lactobacillus acidophilus balance Candida and prevent yeast overgrowth and pathogenic infection. Conditions that disrupt the balance of normal vaginal flora include antibiotic use, oral contraceptives, contraceptive devices, high estrogen levels, and immunocompromised states such as diabetes mellitus and HIV. Of vulvovaginal candidiasis cases, 70-90% are caused by Candida albicans, while the remainder of infections are caused by C glabrata and C tropicalis. Symptoms classically are described as pruritus, vaginal irritation, and dysuria. Thick, curd-like discharge is often present, but scant discharge may also characterize infection. Vaginal edema and erythema are present on examination.
 
Epidemiologically, vaginal Candida infections are important as they may increase viral shedding in HIV-infected women.
 
Cutaneous candidiasis syndromes include the following: 

• Generalized cutaneous candidiasis: This infection is characterized by widespread eruptions with increased severity in the genitocrural folds, anal region, axillae, and hands and feet that occurs in both children and adults.
• Erosio interdigitalis blastomycetica: This is an intertriginous infection, which is predisposed to maceration.
• Candida folliculitis: This is most frequently seen in immunocompromised hosts and among intravenous drug users.
• Candida balanitis: This infection is usually acquired with sexual intercourse with an infected partner. Rash typically begins as vesicles on the penis that develop into patches similar in appearance to thrush. Extension may occur to the scrotum and buttocks. Symptoms include burning and pruritus.
• Intertrigo: This develops in sites where skin surfaces are close in proximity. Lesions begin as vesicopustules that enlarge, rupture, and develop maceration and fissuring. Satellite lesions may be present. A variant form of cutaneous candidiasis in the intertriginous region has a miliary appearance.
• Candidal paronychia: This is associated with frequent hand immersion in water and diabetes mellitus.
• Diaper rash: Skin irritation is exacerbated by wet diapers.
• Perianal candidiasis: Skin maceration and pruritus are frequent with frequent extension to the perineum.

Chronic mucocutaneous candidiasis is a term used to describe a heterogeneous group of Candida infections of the skin, mucous membranes, hair, and nails, which has a protracted course despite typical therapy. It is associated with T-cell lymphocyte dysfunction. A specific subset of patients with this phenomenon have autoimmune polyendocrinopathy-candidosis-ectodermal dystrophy (APECED) syndrome with associated endocrine disorders.
 
Invasive candidal infections
 
Invasive candidiasis is a term used to describe severe and invasive disorders that include candidemia, disseminated candidiasis, deep organ involvement, endocarditis, endophthalmitis, and meningitis. Invasive infection is also described as the isolation of Candida from a normally sterile body site, including blood, peritoneal fluid, pleural fluid, intra-articular fluid, or cerebrospinal fluid.
 
Risk factors for invasive candidiasis include prolonged intensive care unit (ICU) stay (incidence peaks around day 10), presence of a central venous catheter, acute renal failure, treatment with broad-spectrum antibiotics, parenteral nutrition, high APACHE II scores, diabetes, immunosuppressive therapy, surgery (especially upper gastrointestinal tract), hemodialysis, pancreatitis, malignancy, transplantation, and organ dysfunction.
 
Skin manifestations of disseminated candidiasis include clusters of painless pustules on an erythematous base on any area of the body. These lesions may be macular or pustular or may have central necrosis.
 
Acute disseminated candidiasis, or hepatosplenic candidiasis, is most commonly seen in patients with hematologic malignancy who recently had an episode of neutropenia. Symptoms include fever, right upper quadrant pain, and tender hepatosplenomegaly. Multiple organs are frequently involved, and discrete persistent microabscesses occur in the liver, spleen, and kidneys. A palpable erythematous rash may be present indicating evidence of small vessel vasculitis. Presumed etiology is prior episode of candidemia, although invasion through portal vasculature has been theorized.
 
Central nervous system candidiasis usually occurs as a complication of hematogenously disseminated candidiasis. Candida typically forms multiple microabscesses and small macroabscesses scattered throughout the brain. Patients with Candida meningitis usually have meningeal irritation and CSF pleocytosis. Untreated, the mortality rate is high. Intraventricular drains increase risk of CNS candidal infection.
 
Candidal pneumonia occurs rarely as bronchopneumonia originating from endobronchial inoculation or more commonly a hematogenously seeded, nodular diffuse infiltrate. This presentation may be difficult to distinguish from congestive heart failure or Pneumocystis pneumonia. Diagnosis is also complicated by the inability to confirm that positive cultures are not oropharyngeal contaminant or colonization. Candida empyema cases have been documented.
 
Candida can infect both the pericardium and myocardium, and these infections are usually associated with disseminated disease. Candidal pericarditis is rare but fatal without treatment and has been known to cause tamponade. Infective endocarditis with Candida is usually seen in patients with a chronic indwelling intravenous catheter or large-caliber hemodialysis catheter. Other risk factors include congenital cardiac abnormalities, prosthetic valves, and intravenous illicit drug use. Fungal vegetations are often large and more frequently associated with embolic events. The mortality rate is approximately 45% with combined medical and surgical therapy.
 
Urethral candidiasis can occur in both men and women. In women, it is commonly secondary to an extension of Candida vaginitis. In men, it is usually secondary to sexual contact with women with vaginitis. Invasive infections of the bladder and kidneys can occur, though it is typically in immunocompromised patients and secondary to hematogenous spread.
 
Ocular candidiasis can occur in the form of endophthalmitis. Endophthalmitis may occur secondary to exogenous spread, such as trauma or surgery, or endogenous spread as a result of hematologic seeding.
 
Untreated candidemia has been associated with retinal lesions in up to 37% of patients. Candida ophthalmitis begins as a choroidal lesion that progresses to an area of retinal necrosis followed by vitreitis and endophthalmitis. Endophthalmitis is characterized by retinal infiltrates and vitreous abnormalities. Chorioretinal involvement appears as focal, white, infiltrative lesions on the retina. Vitreal haze is present with vitreous extension of the infection. Symptoms include pain and decreased visual acuity. Untreated, ophthalmitis will lead to blindness. Typically, involvement is unilateral, but bilateral cases have been reported. C albicans is the most frequent culprit.
 
Osseous or intra-articular infections may occur secondary to either hematogenous spread or exogenous inoculation during trauma or joint injection. Osteomyelitis occurs most commonly in vertebrae in adults and in long bones in children. Spinal infection can progress to a diskitis. Arthritis can be acute and suppurative, and the knee is most commonly affected. Diagnosis of osteoarticular infections may be delayed as symptoms are frequently more subtle than bacterial infections in the same location and patients often present several weeks to months after an episode of candidemia. Fever is typically absent.
 
Candidal peritonitis is most frequently secondary to peritoneal dialysis catheter seeding or gastrointestinal surgery.
 
Mediastinitis secondary to candidal infection may occur after thoracic surgery.
 
Neonatal invasive candidiasis occurs with an incidence inversely proportional to birth weight. Candida colonization is found in approximately 30% of infants weighing less than 1500 grams at birth weight. Sources of invasive infection in one study included blood (70%), urine (15%), cerebrospinal fluid (10%), and peritoneal fluid (5%). C albicans and C parapsilosis are the most common species found in neonates.

Physical

See History.

Causes

• C albicans is the most common pathogenic species identified. Other species that are commonly found include C glabrata, C parapsilosis, C tropicalis, and C krusei.
• Non-albicans species have been associated with specific patient populations. C glabrata is seen most commonly in patients with neoplastic disease; C tropicalis in patients with leukemia or neutropenia; C parapsilosis among neonates and those with an indwelling intravenous catheter; and C krusei in stem cell transplant recipients and in patients with leukemia who have received fluconazole prophylaxis.
• Denture use, immunosuppressant, antibiotic therapy, and aging are risk factors for oral colonization with C glabrata. C glabrata exhibits lower oral keratinocyte-adherence capacity but higher denture surface adherence ability.

DIFFERENTIALS

Section 4 of 11  

• Authors and Editors
• Introduction
• Clinical
• Differentials
• Workup
• Treatment
• Medication
• Follow-up
• Miscellaneous
• Multimedia
• References

Other Problems to be Considered

Mucocutaneous candidiasis - Contact or allergic dermatitis, folliculitis, Stevens-Johnson syndrome
GI tract candidiasis - Viral infection or gastroesophageal reflux disease (GERD)
Respiratory candidiasis - Bacterial or other fungal infection, acute respiratory distress syndrome (ARDS)
Genitourinary candidiasis - Bacterial infection, pyelonephritis
Candidemia - Bacteria sepsis or endocarditis
Disseminated candidiasis - Bacterial sepsis, meningitis, tuberculosis
Hepatosplenic candidiasis - Abscess, cholecystitis, ascending cholangitis, malignancy recurrence

WORKUP

Section 5 of 11  

• Authors and Editors
• Introduction
• Clinical
• Differentials
• Workup
• Treatment
• Medication
• Follow-up
• Miscellaneous
• Multimedia
• References

Lab Studies

• The criterion standard diagnostic tool for mucocutaneous candidiasis is culture. Cutaneous or mucosal scrapings can be used for a potassium hydroxide smear or Gram stain, which show hyphae, pseudohyphae, and budding yeast forms. The sensitivity of wet mount is as low as 39.6%.
• Savyon Diagnostics currently is developing a rapid yeast detection kit for home diagnosis of vulvovaginal candidiasis. Preliminary data indicate better sensitivity than wet mount, and it costs less than culture.
• Invasive Candida infections are typically difficult to diagnose because the clinical presentation is frequently similar to other disease states or bacterial infections, and cultures are unreliable. In one report, blood cultures were positive in only 50-70% of disseminated candidiasis cases when the disease was proven by autopsy. Thus, nonculture diagnostic techniques are frequently used to aid in diagnosis. The 1,3 beta-glucan assay, which measures the fungal cell was component, has a sensitivity of 70% and specificity of 87%.
• Non–Food Drug Administration (FDA)–approved diagnostic tools include the Platellia Aspergillus ELISA (PA-ELISA) and polymerase chain reaction–based assay.
• The peptide nucleic acid fluorescent in situ hybridization (PNA-FISH) is used to distinguish C albicans from non-albicans Candida species.
• CHROMagear is a specialized media for Candida isolation, which distinguishes C albicans, C tropicalis, and C krusei based on the species’ distinctive pigments.

Imaging Studies

• Imaging studies are not necessary for routine mucocutaneous candidiasis.
• Radiographic evaluations for systemic candidiasis are often nonspecific; thus, differentiation of candidiasis from other disease processes may be difficult.
• Chest radiography may be helpful in making the diagnosis of pulmonary candidiasis.
• • Disease spreads via the airway system. Chest radiographic findings are characterized by bilateral, diffuse, and poorly marginated areas; pulmonary parenchymal densities are common.
  • Other nonspecific findings include air bronchogram and obscure cardiac and hemidiaphragm borders.
  • Hematogenous infection may produce a miliary nodular pattern.
• Esophagography with contrast is indicated for diagnosis of esophagitis caused by Candida species.
• • Peristaltic abnormalities caused by small plaques appear as superficial filling defects. A nodular or cobblestone pattern may be seen.
  • Findings may be similar to those seen with esophagitis caused by cytomegalovirus (CMV) or herpes simplex virus (HSV).
  • Stricture may occur in severe esophageal candidiasis.
• Ultrasonography is useful for diagnosis of microabscesses in the liver, spleen, or kidneys.
• • "Wheel-within-a-wheel" hypoechoic zones surrounded by hyperechoic zones are early findings.
  • Typical "bull's-eye" lesion may evolve from the initial lesion.
  • A uniformly hyperechoic lesion may be observed.
  • Echogenic foci with variable degrees of acoustic shadowing are late findings.
• CT scan allows diagnosis of microabscesses, represented by low-attenuation foci, in the liver, spleen, or kidneys.
• Intravenous pyelography (IVP) may be helpful in the diagnosis of urinary tract candidiasis.
• • Renal edema may be present from multiple microabscesses, deformity of renal outline, diminished renal excretion, papillary necrosis, and candidal fungal balls in the bladder or collecting system may be seen.
  • Hydronephrosis is a common late finding.
• CT scan/MRI is indicated for evaluation of CNS lesions and prior to lumbar puncture.

Procedures

Endoscopy, tissue biopsy, and percutaneous needle aspiration of a body site suspected of Candida infection are recommended to aid in diagnosis. Positive candidal cultures in a normally sterile site should not be disregarded as a contaminant.

TREATMENT

Section 6 of 11  

• Authors and Editors
• Introduction
• Clinical
• Differentials
• Workup
• Treatment
• Medication
• Follow-up
• Miscellaneous
• Multimedia
• References

Emergency Department Care

Mucocutaneous candidiasis is often encountered and treatment initiated in the emergency department. Systemic infections in patients with risk factors for Candida infection should be admitted to the hospital and cultures taken prior to initiating antimicrobial therapy

Other treatment of candidiasis

• Mucocutaneous infection typically responds to topical therapy. Nystatin is the least expensive option for oral thrush, but patients frequently complain of its bitter taste. Clotrimazole troches are as effective and less bitter. Proper denture cleansing and care are important measures against oral candidiasis. 
• Topical therapy is first line for esophageal candidiasis, but systemic therapy is typically required. 
• Intertrigo and diaper rash respond to decreased moisture around the skin. Nystatin powder or cream is used with the addition of a topical steroid for diaper rash. 
• Uncomplicated vulvovaginal candidiasis treatment includes many options of topical or oral therapy. Recurrent candidal vaginitis requires a prolonged course of oral medication.
• Invasive candidiasis typically requires parenterally administered antifungal therapy.
• Candida endocarditis frequently requires both medical and surgical therapy. Valve replacement and vegetation removal is often necessary. Antifungal therapy is typically continued for 6-10 weeks parenterally.
• CNS candidal infection can often successfully be treated without intrathecal instillation.
• Peritoneal candidal infection secondary to peritoneal dialysis may respond to peritoneal infusion of antifungal agents in dialysate fluid.
• Candida keratitis may require corneal grafting if not responsive to treatment.
• Full-term infants with Candida amnionitis typically respond to topical therapy. Premature infants frequently require systemic antifungal agents and have a poorer prognosis.
• Endophthalmitis may require vitrectomy and direct intravitreal antifungal instillation.

Consultations

• Infectious disease specialists are typically involved in cases of invasive candidiasis.
• Gastroenterologists typically perform diagnostic endoscopy.
• Surgical drainage may be required with organ involvement and abscess formation.
• Orthopedic surgeons are involved in the management of osteomyelitis and intra-articular infections. 
• Cardiothoracic surgeons are frequently necessary in the treatment of endocarditis.
• Ophthalmologic consultation should be obtained on all patients with candidemia to exclude evidence of ocular involvement.

MEDICATION

Section 7 of 11  

• Authors and Editors
• Introduction
• Clinical
• Differentials
• Workup
• Treatment
• Medication
• Follow-up
• Miscellaneous
• Multimedia
• References

• Antifungal therapy should be started immediately after necessary cultures have been obtained from all suspected sites of infection.
• Significant advances have been made in the treatment of Candida with the development of newer azoles, echinocandins, and lipid formulations of amphotericin B.

Drug Category: Antifungals, azole

Azoles are fungicidal only at very high concentrations. Azoles function by selectively inhibiting the synthesis of an essential component of fungal cell membrane, ergosterol.

Drug Category: Antifungals, polyenes

Polyenes (nystatin and amphotericin B) bind to ergosterol on the fungal cell membrane and create pores in the membrane resulting in leakage of intracellular proteins thereby destroying the fungal cell.

Drug Category: Antimetabolite

Flucytosine is given occasionally in combination with amphotericin B for central nervous system infections.

Drug Category: Antifungals, echinocandins

Echinocandins have potent fungicidal activity against Candida species and have successfully treated Candida resistant to azoles. These drugs are not metabolized through the CYP450 system. They act by inhibiting the synthesis of an essential cell wall component that is not present in mammalian cells.

FOLLOW-UP

Section 8 of 11  

• Authors and Editors
• Introduction
• Clinical
• Differentials
• Workup
• Treatment
• Medication
• Follow-up
• Miscellaneous
• Multimedia
• References

Further Inpatient Care

• Patients with invasive candidiasis often have a prolonged inpatient course and may require several weeks of parenteral antifungal therapy.
• Removal of invasive catheters with positive fungal culture results is an essential step in management.

Further Outpatient Care

• Uncomplicated vaginal and cutaneous candidiasis
• • When treated in the ED and discharged with medication, patients should be instructed to see their primary physician if symptoms persist or worsen.
  • For recurrent vulvovaginitis, patients should be screened for HIV infection, diabetes mellitus, leukemia, or other immunologic dysfunction. 
• Severe candidiasis: If an underlying disorder is suspected, patients should be referred for workup in an outpatient setting for possible primary causes leading to the immunocompromised state.

In/Out Patient Meds

• Localized mucocutaneous infections are treated with outpatient topical and oral medication. Patients with invasive infections that have stabilized may be discharged with parenteral medications administered at home.

Transfer

• Patients with invasive candidiasis may require transfer to a facility where intensive care and specialty consultations are available.

Deterrence/Prevention

• Screening pregnant women for vaginal infection and subsequently treating the infection, including vaginal candidiasis, reduces preterm delivery rates by 50%.
• Multiple studies have been performed evaluating fluconazole prophylaxis in the ICU; however, the studies had either limited numbers or were performed in only one center, thereby limiting the ability to apply the evidence to the general population.
• Candida prevention in the neonatal intensive care unit is also controversial. Fluconazole prophylaxis can lead to the emergence of Candida species that are not susceptible to fluconazole. This is a concern as mortality varies substantially by Candida species. C glabrata is associated with the highest mortality rate in neonates. Studies have demonstrated that less frequent dosing may delay the emergence of antifungal resistance but more evidence-based data are required.

Complications

• Untreated candidemia can lead to metastatic foci of virtually any organ system and may lead to blindness, organ failure, and death.

Prognosis

• Prognosis varies based on location of infection. Local mucocutaneous infections typically respond well to medical therapy. Response to invasive infection is determined by how quickly infection with Candida is recognized and treatment is initiated as well as underlying host immune response and comorbidities.

Patient Education

• Patients should be informed that immunocompromising agents and widespread administration of antibiotics may increase the likelihood of developing candidal infections.
• Patients should be educated to follow diets low in refined sugars and to avoid clothing that is tight and/or synthetic. Cotton underclothing may be beneficial.
• For excellent patient education resources, visit eMedicine's Yeast and Fungal Infections Center; Children's Health Center; and Skin, Hair, and Nails Center. Also, see eMedicine's patient education articles Candidiasis (Yeast Infection), Understanding Vaginal Yeast Infection Medications, Yeast Infection Diaper Rash, and Yeast Infection Skin Rash.

MISCELLANEOUS

Section 9 of 11  

• Authors and Editors
• Introduction
• Clinical
• Differentials
• Workup
• Treatment
• Medication
• Follow-up
• Miscellaneous
• Multimedia
• References

Medical/Legal Pitfalls

• Many physicians treating patients with invasive candidiasis are not aware of the risk and consequences of ocular candidiasis. A formal ophthalmologic examination is required in all patients with systemic disease.

Special Concerns

• Invasive candidiasis requires clinical suspicion and is often difficult to diagnose. Missed infections have high morbidity and mortality. Physicians must consider Candida infection as a possible pathogen in patients with risk factors. Because cultures frequently do not grow Candida species in known patients with candidemia, positive blood cultures for Candida should never be regarded as a contaminant. Antifungal therapy must be considered in critically ill patients on broad-spectrum antibiotics, especially if they are known to be colonized with Candida species.

MULTIMEDIA

Section 10 of 11  

• Authors and Editors
• Introduction
• Clinical
• Differentials
• Workup
• Treatment
• Medication
• Follow-up
• Miscellaneous
• Multimedia
• References

Media file 1:  Candidiasis. Image courtesy of Hon Pak, MD.
	View Full Size Image
Media type:  Photo

Media file 2:  Candidiasis. A moist, erosive, pruritic patch of the perianal skin and perineum (with satellite pustule formation) is demonstrated in this woman with extensive candidosis. Image courtesy of Matthew C Lambiase, DO.
	View Full Size Image
Media type:  Photo

Media file 3:  Candidiasis. Discrete superficial pustules developed within hours of birth on the hand of an otherwise healthy newborn. A potassium hydroxide preparation revealed spores and pseudomycelium, and culture demonstrated the presence of Candida albicans. Image courtesy of Matthew C Lambiase, DO.
	View Full Size Image
Media type:  Photo

Media file 4:  Candidiasis. Dry, red, superficially scaly, pruritic macules and patches on the penis represent candidal balanitis. Image courtesy of Matthew C Lambiase, DO.
	View Full Size Image
Media type:  Photo

Media file 5:  Candidiasis. White plaques are present on the buccal mucosa and the undersurface of the tongue and represent thrush. When wiped off, the plaques leave red erosive areas. Image courtesy of Matthew C Lambiase, DO.
	View Full Size Image
Media type:  Photo

Media file 6:  Candidiasis. Erythema, maceration, and satellite pustules in the axilla, accompanied by soreness and pruritus, result in a form of intertrigo. Image courtesy of Matthew C Lambiase, DO.
	View Full Size Image
Media type:  Photo

Media file 7:  Candidiasis. A nailfold with candidal infection becomes erythematous, swollen, and tender with an occasional discharge. (Image courtesy of Matthew C Lambiase, DO.
	View Full Size Image
Media type:  Photo

Media file 8:  Candidiasis. Soreness and cracks at the lateral angles of the mouth (angular cheilitis) is a frequent expression of candidosis in elderly individuals. Image courtesy of Matthew C Lambiase, DO.
	View Full Size Image
Media type:  Photo

Media file 9:  Candidiasis. Fine superficial pustules on an erythematous patchy base are suggestive of candidosis. Image courtesy of Matthew C Lambiase, DO.
	View Full Size Image
Media type:  Photo

Media file 10:  Candidiasis. Candida infection should be in the differential diagnosis when one or more nails become discolored, has subungual discoloration, nailplate separation from the nailbed, and lack evidence of a dermatophyte. Image courtesy of Matthew C Lambiase, DO.
	View Full Size Image
Media type:  Photo

REFERENCES

Section 11 of 11